CSPC Innovation Pharmaceutical Co Ltd Class A (300765) — Capital Reinvestment Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Capital Reinvestment Ratio of 5.62x as of June 2024, meaning it reinvests 6% of its operating cash flow (CN¥33.92 Million) in capital expenditures (CN¥190.69 Million). Check CSPC Innovation Pharmaceutical Co Ltd Cl tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CSPC Innovation Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio (2014–2023)
This chart tracks CSPC Innovation Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of CSPC Innovation Pharmaceutical Co Ltd Cl.
Annual Capital Reinvestment Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2023)
Year-by-year Capital Reinvestment Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2023. See 300765 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | CN¥927.24 Million | CN¥95.73 Million | ▼ -42.0% |
| 2022 | 0.18x | CN¥640.72 Million | CN¥114.05 Million | ▼ -22.3% |
| 2021 | 0.23x | CN¥292.09 Million | CN¥66.92 Million | ▼ -32.1% |
| 2020 | 0.34x | CN¥349.07 Million | CN¥117.74 Million | ▲ +0.3% |
| 2019 | 0.34x | CN¥315.38 Million | CN¥106.10 Million | ▼ -8.9% |
| 2018 | 0.37x | CN¥159.73 Million | CN¥58.96 Million | ▼ -98.9% |
| 2017 | 32.90x | CN¥1.30 Million | CN¥42.78 Million | ▲ +2956.1% |
| 2016 | 1.08x | CN¥137.27 Million | CN¥147.79 Million | ▲ +153.1% |
| 2015 | 0.43x | CN¥112.05 Million | CN¥47.67 Million | ▲ +391.3% |
| 2014 | 0.09x | CN¥93.36 Million | CN¥8.09 Million | — |